These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12480695)

  • 1. Non-T-cell-depleted HLA haploidentical stem cell transplantation in advanced hematologic malignancies based on the feto-maternal michrochimerism.
    Shimazaki C; Ochiai N; Uchida R; Okano A; Fuchida S; Ashihara E; Inaba T; Fujita N; Maruya E; Nakagawa M
    Blood; 2003 Apr; 101(8):3334-6. PubMed ID: 12480695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful reduced-intensity stem cell transplantation from an HLA haploidentical 3-loci-mismatched donor on the basis of fetomaternal microchimerism in a patient with advanced acute myeloid leukemia.
    Uoshima N; Kamitsuji Y; Maruya E; Saji H
    Int J Hematol; 2003 Jul; 78(1):69-72. PubMed ID: 12894854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
    Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
    Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful non-T cell-depleted HLA haplo-identical three-loci mismatched hematopoietic stem cell transplantation from mother to son based on the feto-maternal microchimerism in chronic myelogenous leukemia.
    Ochiai N; Shimazaki C; Fuchida S; Okano A; Sumikuma T; Ashihara E; Inaba T; Fujita N; Maruya E; Nakagawa M
    Bone Marrow Transplant; 2002 Dec; 30(11):793-6. PubMed ID: 12439703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerism.
    Ichinohe T; Uchiyama T; Shimazaki C; Matsuo K; Tamaki S; Hino M; Watanabe A; Hamaguchi M; Adachi S; Gondo H; Uoshima N; Yoshihara T; Hatanaka K; Fujii H; Kawa K; Kawanishi K; Oka K; Kimura H; Itoh M; Inukai T; Maruya E; Saji H; Kodera Y;
    Blood; 2004 Dec; 104(12):3821-8. PubMed ID: 15280193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful non-T-cell-depleted HLA-haploidentical 3-loci mismatched bone marrow transplantation.
    Yagyu S; Kuroda H; Fujiki A; Tamura S; Iehara T; Morimoto A; Hosoi H; Sugimoto T; Imashuku S
    Eur J Haematol; 2005 Jun; 74(6):529-32. PubMed ID: 15876259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients.
    Kaynar L; Demir K; Turak EE; Öztürk ÇP; Zararsız G; Gönen ZB; Gökahmetoğlu S; Şıvgın S; Eser B; Köker Y; Solmaz M; Ünal A; Çetin M
    Hematology; 2017 Apr; 22(3):136-144. PubMed ID: 27724812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-T-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation from a family donor based on fetomaternal microchimerism in pediatric hematologic malignancies.
    Ishida H; Morimoto A; Yoshihara T; Kuroda H; Mori K; Fujii N; Tamura S; Hibi S; Todo S; Maruya E; Imashuku S
    J Pediatr Hematol Oncol; 2004 Jan; 26(1):68-71. PubMed ID: 14707719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful non-T-cell-depleted HLA-haploidentical stem cell transplantation (SCT) with reduced-intensity conditioning from a second child for late graft failure after the first HLA-haploidentical SCT for MDS/overt leukemia based on feto-maternal microchimerism.
    Fuchida S; Nakano S; Yamada N; Uchida R; Okano A; Okamoto M; Maruya E; Saji H; Shimazaki C
    Bone Marrow Transplant; 2005 May; 35(10):1031-2. PubMed ID: 15806124
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia.
    Yahng SA; Kim JH; Jeon YW; Yoon JH; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Kim HJ
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):119-29. PubMed ID: 25300871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center.
    Wang Y; Liu DH; Liu KY; Xu LP; Zhang XH; Han W; Chen H; Chen YH; Wang FR; Wang JZ; Sun YQ; Huang XJ
    Cancer; 2013 Mar; 119(5):978-85. PubMed ID: 23097265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The outcomes of the thirty patients with refractory leukemia treated with related HLA haploidentical stem cells transplantation].
    Wu BY; Guo KY; Song CY; Wu LX; Yang YL; Li YH; Xiao LL
    Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):130-2. PubMed ID: 16624123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic stem cell transplantation and cellular therapy.
    Kolb HJ
    HLA; 2017 May; 89(5):267-277. PubMed ID: 28371460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-CSF-primed haploidentical marrow transplantation without ex vivo T cell depletion: an excellent alternative for high-risk leukemia.
    Ji SQ; Chen HR; Wang HX; Yan HM; Zhu L; Liu J; Xue M; Xun CQ
    Bone Marrow Transplant; 2002 Dec; 30(12):861-6. PubMed ID: 12476277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced-intensity non-T-cell depleted HLA-haploidentical stem cell transplantation for older patients based on the concept of feto-maternal tolerance.
    Obama K; Utsunomiya A; Takatsuka Y; Takemoto Y
    Bone Marrow Transplant; 2004 Nov; 34(10):897-9. PubMed ID: 15361902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-mismatched haploidentical transplantation using low-dose anti-thymocyte globulin (ATG: thymoglobulin).
    Kako S; Akahoshi Y; Harada N; Nakano H; Kameda K; Ugai T; Yamasaki R; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Ashizawa M; Terasako-Saito K; Kimura SI; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kanda Y
    Hematology; 2017 Apr; 22(3):129-135. PubMed ID: 27905258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term feto-maternal microchimerism: nature's hidden clue for alternative donor hematopoietic cell transplantation?
    Ichinohe T; Maruya E; Saji H
    Int J Hematol; 2002 Oct; 76(3):229-37. PubMed ID: 12416733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.